Nuvalent Stock Performance
| NUVL Stock | USD 76.66 0.36 0.47% |
The company secures a Beta (Market Risk) of 0.9, which conveys possible diversification benefits within a given portfolio. Nuvalent returns are very sensitive to returns on the market. As the market goes up or down, Nuvalent is expected to follow. At this point, Nuvalent has a negative expected return of -0.13%. Please make sure to verify Nuvalent's maximum drawdown, daily balance of power, as well as the relationship between the Daily Balance Of Power and period momentum indicator , to decide if Nuvalent performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Over the last 90 days Nuvalent has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest weak performance, the Stock's basic indicators remain persistent and the latest mess on Wall Street may also be a sign of long-standing gains for the company institutional investors. ...more
Actual Historical Performance (%)
One Day Return (0.47) | Five Day Return 6.13 | Year To Date Return (4.16) | Ten Year Return 308.85 | All Time Return 308.85 |
1 | Acquisition by Balcom Alexandra of 4728 shares of Nuvalent at 1.08 subject to Rule 16b-3 | 12/17/2024 |
2 | Disposition of 591 shares by Shair Matthew of Nuvalent at 84.17 subject to Rule 16b-3 | 12/23/2024 |
3 | Acquisition by James Porter of 112500 shares of Nuvalent at 78.09 subject to Rule 16b-3 | 01/06/2025 |
4 | Acquisition by Turner Christopher Durant of 18750 shares of Nuvalent subject to Rule 16b-3 | 01/08/2025 |
5 | Disposition of 2513 shares by Darlene Noci of Nuvalent at 88.79 subject to Rule 16b-3 | 01/10/2025 |
6 | Nuvalent Announces Corporate Updates and Anticipated Milestones for 2025 | 01/14/2025 |
7 | Disposition of 108 shares by Shair Matthew of Nuvalent at 85.0 subject to Rule 16b-3 | 01/27/2025 |
8 | Acquisition by Balcom Alexandra of 10000 shares of Nuvalent at 27.85 subject to Rule 16b-3 | 02/10/2025 |
9 | Q1 Earnings Estimate for Nuvalent Issued By Leerink Partnrs - MarketBeat | 02/13/2025 |
10 | Disposition of 800 shares by James Porter of Nuvalent at 79.01 subject to Rule 16b-3 | 02/18/2025 |
11 | Disposition of 27000 shares by James Porter of Nuvalent at 27.85 subject to Rule 16b-3 | 02/20/2025 |
12 | Disposition of 302 shares by Shair Matthew of Nuvalent at 79.13 subject to Rule 16b-3 | 02/24/2025 |
13 | Disposition of 1382 shares by Shair Matthew of Nuvalent at 78.49 subject to Rule 16b-3 | 02/25/2025 |
14 | Nuvalent Inc Announces Pipeline Progress and Financial Results | 02/27/2025 |
15 | Decoding Nuvalent Inc A Strategic SWOT Insight | 02/28/2025 |
16 | Disposition of 8015 shares by Darlene Noci of Nuvalent at 6.89 subject to Rule 16b-3 | 03/06/2025 |
17 | Disposition of 4000 shares by Darlene Noci of Nuvalent at 1.08 subject to Rule 16b-3 | 03/07/2025 |
18 | Disposition of 10000 shares by Balcom Alexandra of Nuvalent at 27.85 subject to Rule 16b-3 | 03/13/2025 |
19 | Here are Fridays biggest analyst calls Nvidia, Apple, Tesla, Peloton, Chipotle, Six Flags, American Express more | 03/14/2025 |
| Begin Period Cash Flow | 335.4 M |
Nuvalent |
Nuvalent Relative Risk vs. Return Landscape
If you would invest 8,464 in Nuvalent on December 19, 2024 and sell it today you would lose (798.00) from holding Nuvalent or give up 9.43% of portfolio value over 90 days. Nuvalent is currently does not generate positive expected returns and assumes 2.6461% risk (volatility on return distribution) over the 90 days horizon. In different words, 23% of stocks are less volatile than Nuvalent, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Nuvalent Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Nuvalent's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Nuvalent, and traders can use it to determine the average amount a Nuvalent's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0504
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | NUVL |
Estimated Market Risk
| 2.65 actual daily | 23 77% of assets are more volatile |
Expected Return
| -0.13 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.05 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Nuvalent is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Nuvalent by adding Nuvalent to a well-diversified portfolio.
Nuvalent Fundamentals Growth
Nuvalent Stock prices reflect investors' perceptions of the future prospects and financial health of Nuvalent, and Nuvalent fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Nuvalent Stock performance.
| Return On Equity | -0.29 | ||||
| Return On Asset | -0.19 | ||||
| Current Valuation | 4.4 B | ||||
| Shares Outstanding | 66.16 M | ||||
| Price To Earning | (0.06) X | ||||
| Price To Book | 5.15 X | ||||
| EBITDA | (280.37 M) | ||||
| Net Income | (260.76 M) | ||||
| Cash And Equivalents | 256.96 M | ||||
| Cash Per Share | 5.31 X | ||||
| Total Debt | 71.96 M | ||||
| Debt To Equity | 2.81 % | ||||
| Current Ratio | 25.79 X | ||||
| Book Value Per Share | 14.99 X | ||||
| Cash Flow From Operations | (185.06 M) | ||||
| Earnings Per Share | (3.93) X | ||||
| Market Capitalization | 5.51 B | ||||
| Total Asset | 1.14 B | ||||
| Retained Earnings | (547.05 M) | ||||
| Working Capital | 1.08 B | ||||
| Current Liabilities | 5.46 M | ||||
About Nuvalent Performance
By examining Nuvalent's fundamental ratios, stakeholders can obtain critical insights into Nuvalent's financial health, operational efficiency, and overall profitability. These insights assist in making well-informed investment and management decisions. For example, a high Return on Assets and Return on Equity would indicate that Nuvalent is effectively utilizing its assets and equity to generate significant profits, enhancing its appeal to investors. On the other hand, low ROA and ROE values could reveal issues in asset and equity management, highlighting the need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.23) | (0.24) | |
| Return On Capital Employed | (0.26) | (0.24) | |
| Return On Assets | (0.23) | (0.24) | |
| Return On Equity | (0.24) | (0.23) |
Things to note about Nuvalent performance evaluation
Checking the ongoing alerts about Nuvalent for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Nuvalent help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Nuvalent generated a negative expected return over the last 90 days | |
| Net Loss for the year was (260.76 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Nuvalent currently holds about 256.96 M in cash with (185.06 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 5.31. | |
| Nuvalent has a frail financial position based on the latest SEC disclosures | |
| Over 97.0% of the company shares are owned by institutional investors | |
| Latest headline from cnbc.com: Here are Fridays biggest analyst calls Nvidia, Apple, Tesla, Peloton, Chipotle, Six Flags, American Express more |
- Analyzing Nuvalent's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Nuvalent's stock is overvalued or undervalued compared to its peers.
- Examining Nuvalent's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Nuvalent's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Nuvalent's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Nuvalent's stock. These opinions can provide insight into Nuvalent's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Nuvalent. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. For more information on how to buy Nuvalent Stock please use our How to buy in Nuvalent Stock guide.You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Nuvalent. If investors know Nuvalent will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Nuvalent listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Nuvalent is measured differently than its book value, which is the value of Nuvalent that is recorded on the company's balance sheet. Investors also form their own opinion of Nuvalent's value that differs from its market value or its book value, called intrinsic value, which is Nuvalent's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Nuvalent's market value can be influenced by many factors that don't directly affect Nuvalent's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Nuvalent's value and its price as these two are different measures arrived at by different means. Investors typically determine if Nuvalent is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Nuvalent's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.